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Abstract: Investigating the polyphenolic profile of natural Rosmarinus officinalis and Ocimum basilicum
populations may reveal essential compounds that have biological activities. Natural populations
of R. officinalis and O. basilicum in Northern Riyadh were investigated by HPLC-DAD analyses.
Several polyphenols, including rosmarinic acid, gentisic acid, 3,4-dihydroxyphenylacetic acid,
rutoside, and others, out of 38 screened were confirmed. Rosmarinic acid was the major polyphenol
in both of R. officinalis and O. basilicum. R. officinalis methanolic leaf extracts contained other
phenols such as gentisic acid while O. basilicum contained also 3,4-dihydroxyphenylacetic acid and
rutoside as well as others. R. officinalis showed higher antioxidant activities than O. basilicum using
2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric reducing antioxidant power (FRAP), and β-carotene
bleaching assays. These higher activities are associated with a higher composition of rosmarinic
acid in leaf extracts. The antioxidant activities of O. basilicum were attributed to identified phenols
of rosmarinic acid, 3,4-dihydroxyphenylacetic acid, and rutoside. There were antiproliferative
and cytotoxic activities of leaf extracts, as well as identified polyphenols, against several cancer
cells. These activities were attributed to the accumulation of necrotic and apoptotic cells in treated
cancer cells with leaf extracts as well as identified polyphenols. The antibacterial and antifungal
activities of leaf extracts were mainly attributed to 3,4-dihydroxyphenylacetic acid and rutoside in
O. basilicum and rosmarinic acid and caffeic acid in R. officinalis. This study proved that R. officinalis and
O. basilicum natural populations might be considered as promising sources of natural polyphenols
with biological activities.
Keywords: Rosmarinus officinalis; Ocimum basilicum; leaf extract; phenolic acids; flavonoids;
antiproliferative; cytotoxicity; antioxidant; antibacterial; antifungal
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1. Introduction
Polyphenols are important plant secondary metabolites that are used for the control of aging as
antioxidants [1] and the control microbes as antibacterial and antifungal agents [2,3]. Other applications
of polyphenols had been discovered, such as anticancer agents [4–7], and food preservatives [8].
The biological activities of polyphenols as antioxidants are related to the ability to scavenge free radicals
and the modulation of metal chelation reactions [4,9]. Polyphenols activate the detoxification enzymes
and reduce free radicals [4,9]. The antiproliferative and apoptotic activities of polyphenols against
cancer cells is attributed to the control of cell cycle arrest, as well as the molecular regulation of cancer
related genes [4,9–11].
The Lamiaceae family contains dozens of medicinal plants with important economic output,
including Rosmarinus officinalis and Ocimum basilicum. R. officinalis (syn. R. angustifolius Mill., R. flexuosus
Jord. & Fourr., Salvia rosmarinus Schleid.)—rosemary—is one of the most widely used herbs in food
and cosmetics, as well as in medicine. The fresh or dry stems and leaves are consumed as spice
or manufactured for pharmaceutical applications. R. officinalis is a perennial herb originated in the
Mediterranean region, and contains a large number of ecotypes that differ morphologically and
chemically [12]. R. officinalis is widely used by desert communities in Saudi Arabia, where it grows
wild. Notable is the fact that the phytochemical composition of R. officinalis depends on many factors,
e.g., site of occurrence, chemotypes, or varieties [13]. The leaf of R. officinalis is officially recognized as
the raw material [14]. The R. officinalis essential oil (Rosmarini aetheroleum), is listed in the European
Pharmacopoeia [15] and American Pharmacopoeia [16], as well as in the World Health Organization
Monographs [17]. The R. officinalis essential oil obtained by steam distillation from the leaves (up to
2.5%), which are the most responsible for its biological activity. The main constituents are: camphor
(5.0–21%), 1,8-cineole (15–55%), α-pinene (9.0–26%), borneol, camphene, β-pinene, and limonene in
changing proportions, depending on growth stage and bioclimatic conditions [18]. Major polyphenols
confirmed in R. officinalis leaf extracts, are flavonoids: apigenin, luteolin, nepetin, nepitrin, and phenolic
acids: rosmarinic acid (c.a. 23%), chlorogenic acid, caffeic acid, and other organic acids like: ursolic
acid, betulinic acid, carnosic acid, and carnosol [19]. The extracts obtained from R. officinalis are used as
a natural antioxidant, in rheumatic complaints, and in circulatory disorders [17]. These plants have
antihepatotoxic [20], antimicrobial [21], and antispasmodic [22] activities. Traditionally, R. officinalis is
used as cholagogue, diaphoretic, digestant, diuretic, emmenagogue, laxative, and a tonic remedy [23].
The O. basilicum (syn. Basilicum citratum Rumph., Ocimum album L., Ocimum americanum
Jacq.)—sweet basil; common basil—is another medicinal herb that originated in the Mediterranean
region and is grown regularly all over the world. The Ocimum genus contains a large number of
species, which are the subject of hybridization and within-population variation [24]. In addition, large
number of commercial cultivars are added to the market every year. The morphological and chemical
characteristics of Ocimum are highly diverse [24,25]. The O. basilicum essential oil obtained from leaves
and/or stems and flowers is recognized as raw material [26]. Basil essential oil contains numerous
compounds, mainly monotherpenenoids (linalool (57–60%), camphor, limonene, 1,8-cineole, geraniol),
and phenylpropanoids (eugenol, methyleugenol, chavicol, estragole, methyl-cinnamate) [27]. Volatile oil
composition is strictly dependent on O. basilicum chemotypes, cultivars, flower and leaf colours,
and aroma, as well as the origin of the plant [27]. The O. basilicum leaves also contain several
polyphenols, including flavonoids (nevadensin, salvigenin, cirsileol, eupatorin, apigenin, acacetin,
cirsimaritin, quercetin, and ladanein) [28], and phenolic acids (rosmarinic acid, caffeic acid, and caftaric
acid) [29]. However, natural populations of this species may have a different chemical composition
and biological activities. Traditionally, O. basilicum is used as a tonic and for the treatment of nausea,
flatulence, and dysentery. The O. basilicum essential oil has been found to be beneficial for the alleviation
of mental fatigue, cold, spasms, and rhinitis [30]. Scientific studies have confirmed the analgesic,
anti-inflammatory, antioxidant, antimicrobial, anti-ulcerogenic, chemomodulatory, immunomodulatory,
hypolipidaemic, and hypoglycaemic activities of O. basilicum [31].
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In this investigation, the polyphenolic composition and biological activities of R. officinalis and O.
basilicum natural populations were explored qualitatively and quantitatively using the HPLC-DAD
method. The antioxidant, antiproliferative, cytotoxic, antibacterial, and antifungal activities were
examined as a novel investigation of R. officinalis and O. basilicum natural populations in Northern
Saudi Arabia.
2. Materials and Methods
2.1. Plant Material and Preparation
The leaf extracts of Rosmarinus officinalis L. and Ocimum basilicum L. were obtained from natural
populations growing in the Riyadh region. Plants were identified by Hosam Elansary and vouchered
at the College of Food and Agricultural Sciences, King Saud University (Hosam0002213–101).
Lyophilized dried leaves were powdered then extracted with methanol (0.2 g DW (dry weight)
in 10 mL) by sonication twice for 30 min at 30 ◦C. Purification was conducted using Whatman paper,
then the residues were dried at room temperature (to lose methanol). Finally, the residues were frozen
at −80 ◦C. For HPLC analyses, and the residues were dissolved in methanol (1 mL, Merck, Berlin,
Germany) while for bioassays, the methanol was totally removed using a rotary evaporator [32].
The experiments were approved by the animal committee of the college of Agriculture, Damietta
University (2018-2019-75365). Bacteria, fungi, and cancer cell lines (ATTC collection) were obtained
from the Faculty of Agriculture, Alexandria, Egypt.
2.2. Analyses of Phenolic Compounds
The analyses were conducted using HPLC-DAD method on Merck-Hitachi liquid chromatograph
(LaChrom Elite, Berlin, Germany) with Purospher RP-18e column (250 × 4 mm; 5 µm, Merck, Berlin,
Germany) and DAD detector (L-2455, Berlin, Germany). As mobile phase two solvents were used:
methanol (A) and 0.5% acetic acid + methanol 1:4 (v/v). The gradient program was as follows:
0–20′ 100% B; 20–35′ 100%–80% B; 35–55′ 80%–60% B; 55–70′ 60%–0% B; 70–75′ 0%; 0%–100% B for
75–80′; 80–90′ 100% B. Other parameters of analysis were temperature—25 ◦C, flow rate—1 mL min−1,
injection volume—20 µL, wavelength from 210 to 400 nm. Quantitative analysis was measured at 254
nm. The HPLC method was validated earlier by our group [33,34]. Compounds were identified by
a comparison of retention times and UV spectra with standards. The quantification was calculated
using calibration curve. For qualification and quantification, commercially available standards of the
following 22 phenolic acids were used: cinnamic acid and its derivatives (caffeic acid, o-coumaric
acid, m-coumaric acid, p-coumaric acid, ferulic acid, hydrocaffeic acid, isoferulic acid, and sinapic
acid); benzoic acid and its derivatives (3,4-dihydroxyphenylacetic acid, ellagic acid, gallic acid, gentisic
acid, p-hydroxybenzoic acid, protocatechuic acid, salicylic acid, syringic acid, and vanillic acid), and
depsides (chlorogenic acid, neochlorogenic acid, and rosmarinic acid). The standards of 7 flavonoids
(cynaroside, myricetin, naringin, quercetin, kaempferol, rhamnetin, and luteolin) and 9 flavonoid
glycosides (apigetrin, cynaroside, hyperoside, quercitrin, robinin, rutoside, isoquercetin, trifolin, and
vitexin) were used. In total, 38 compounds were screened and all chemicals were obtained from
Sigma-Aldrich, Berin, Germany.
2.3. Anticancer Activities
Antiproliferative and cytotoxic effects of R. officinalis and O. basilicum leaf extracts were tested against
Jurkat, MCF-7, HeLa, HT-29, and HEK-293 (normal human cells) (ATTC, Berlin, Germany), [4,5,35].
To determine the changes in cells viability, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay was employed. DMSO (1%) solubilized leaf extracts were added to standard
media (MEM) containing (10% FBS, 0.1 mM non-essential amino acids, 17.8 mM NaHCO3, and 1 mM
sodium pyruvate) and cancer cells in 75 cm2 flasks. Cancer cells were prepared in a microtiter plates
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using 4 × 10−4 cells per µL in a 270 µL medium for 48 h (37 ◦C, 5% CO2). Serial concentrations of leaf
extracts were used until reaching a final concentration of 50, 100, 200, 300, and 400 µg/mL.
A washing procedure was performed using PBS, then the MTT dissolved in PBS was added at
12 mM to the medium, then the isoprobanol (0.04 N HCl) was also mixed and the mixture was left for
40 min. Negative control (untreated) and a positive couple (vinblastine sulfate and taxol) were used.
The following equation was used to calculate the inhibition activity percentage (IAA) obtained from
measuring the absorbance at a 570 nm wavelength:
IAA =
(AB570nm)C − (AB570nm)s
(AB570nm)C
× 100
where AB is the absorbance, (AB570 nm)C and (AB570 nm)s are Abs.570 nm of control and
sample, respectively.
The IC50 was determined by plotting the percentage of viable cells against extract concentration
in µg mL−1. The IC50 was applied in the flow cytometry assay to investigate the cytotoxic activities
R. officinalis and O. basilicum leaf extracts, then the apoptotic cell populations were determined (FAC
Scan, USA) [4,35,36].
2.4. Antioxidant Activity
R. officinalis and O. basilicum leaf extract antioxidant activities were investigated using β-carotene
bleaching, ferric reducing antioxidant power (FRAP), and 2,2-diphenyl-1-picrylhydrazyl (DPPH)
assays [5,24,37–39]. Lyophilized dried leaves were powdered then extracted with methanol (0.2 g
DW (dry weight) in 10 mL) by sonication twice for 30 min at 30 ◦C. Purification was conducted
using Whatman paper, then the residues were dried at room temperature (to lose methanol). Finally,
the residues were frozen at −80 ◦C. The IC50 (µg mL−1) was defined as the amount of extracts required
to scavenge 50% of β-carotene bleaching/DPPH solution. This value (IC50) was determined by plotting
the inhibition percent against extract concentration. The butylated hydroxytoluene (BHT) was used
as standard for β-carotene bleaching/DPPH. The absorbance was measured at 470 nm for β-carotene
bleaching, at 517 nm for DPPH, and at 593 nm for FRAP. The FRAP reagent was prepared as described
before [40–43]. Aliquots (100 µL) of leaf extracts/Trolox (Sigma-Aldrich, Berlin, Germany) were added
to the reagent (3 mL), then mixed and incubated for 30 min at 37 ◦C. The calibration procedure of
FRAP was done by applying serial dilutions of Trolox (0–0.5 mmol/L), as standard. Experiments were
conducted in triplicated and repeated twice.
2.5. Antibacterial Effect
Bacterial isolates of L. monocytogenes (clinical isolate), S. aureus (ATCC 6538), E. coli (ATCC 35210)
ria, B. cereus (ATCC 14579), P. aeruginosa (ATCC 27853), and M. flavus (ATCC 10240), were used in this
assay. A microtiter plates based protocol (micro-dilution) was used following [7,40–42], by preparing
serial concentrations of the extracts that were mixed with bacterial inoculum of 1.0 × 104 CFU in each
well with 100 µL tryptic soy broth per well, then incubated for one day at 37 ◦C on a rotary shaker.
The minimum inhibitory concentration (MIC) was defined as the lowest concentration that caused no
visible growth by binocular microscope. The MBC was determined using serial subculturing of extracts
(2 µL), and the minimal concentration caused eliminating of 99.5% of each inoculum was considered as
the MBC value. The optical density (OD) was determined using 655 nm wave length. The positive
control (streptomycin) at 0.01–10 mg/mL was used alongside negative one (DMSO, 1%).
2.6. Antifungal Effect
M. × piperita and M. longifolia antifungal effects were determined against P. ochrochloron (ATCC
48663), A. ochraceus (ATCC 12066), C. albicans (ATCC 12066), A. niger (ATCC 6275), A. flavus (ATCC 9643),
and P. funiculosum (ATCC 56755) using a micro-dilution method [36,40,41]. The MIC was determined
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by stereomicroscope. The minimum fungicidal concentration (MFC) was determined by preparing
serial dilutions of 2 µL extracts in sub-cultures of fungi at 28 ◦C for 72 h in microtiter plates that
contained 100 µL of broth medium. Ketoconazole (KTZ, 1–3500 µg/mL) was used as a positive control.
The DMSO (1%) was also used.
2.7. Statistical Analyses
To determine significant differences, the least significance difference (LSD) were determined using
SPSS software. The standard deviation (SD) was the mean of three replicates.
3. Results
3.1. Polyphenol Profiling of Rosmarinus Officinalis and Ocimum Basilicum Leaf Extracts
In the R. officinalis methanolic leaf extract, the HPLC-DAD qualitative and quantitative analyses
of selected phenolic compounds confirmed very high amount of rosmarinic acid (4040.00 mg/100 g
DW (dry weight)). Moreover, other polyphenols, including genistic aicd (199.9 mg/100 g DW), vanilic
acid (36.6 mg/100 g DW), and caffeic acid (27.6 mg/100 g DW) were determined (Figure 1A, Table 1).
In O. basilicum leaf extracts, a larger number of polyphenols were determined (8 phenolic acids and
1 flavonoid). In phenolic acids, the major one was rosmarinic acid (1128.5 mg/100 g DW), followed by
3,4-dihydroxyphenylacetic acid (312.3 mg/100 g DW), caftaric acid (60.3 mg/100 g DW), neochlorogenic
acid (38.6 mg/100 g DW), isochlorogenic acid (30.0 mg/100 g DW), caffeic acid (17.6 mg/100 g DW),
ferulic acid (14.4 mg/100 g DW), and a small amount of vanilic acid (1.1 mg/100 g DW) (Figure 1B,
Table 1).
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Figure 1. The examples of HPLC-DAD chromatographic separation (λ = 254 nm) of leaf extracts
of: (A) R. officinalis (1—gentisic acid, 2—vanillic acid, 3—caffeic acid, 4—rosmarinic acid); and (B)
O. basilicum (1—neochlorogenic acid, 2—caftaric acid, 3—3,4-dihydroxyphenylacetic acid, 4—vanillic
acid, 5—caffeic acid, 6—ferulic acid, 7—isochlorogenic acid, 8—rutoside, 9—rosmarinic acid).
Table 1. The contents of polyphenols in R. officinalis and O. basilicum leaf extracts (mg/100g DW ± SD).
Compound Rosmarinus officinalis Ocimum basilicum
Caffeic acid 27.6 ± 3.6 17.6 ± 1.3
Caftaric acid nd * 60.3 ± 4.5
3,4-Dihydroxyphenylacetic acid nd 312.3 ± 20.4
Ferulic acid nd 14.4 ± 1.7
Gentisic acid 119.9 ± 2.0 nd
Isochlorogenic acid nd 30.0 ± 3.3
Neochlorogenic acid nd 38.6 ± 2.7
Rosmarinic acid 4040.0 ± 189.2 1128.5 ± 70.4
Vanillic acid 36.6 ± 1.7 1.1 ± 0.0
Rutoside nd 139.4 ± 18.8
* nd—not detected.
3.2. Antioxidant Effects
R. officinalis and O. basilicum leaf extracts, as well as major compounds, showed significant
antioxidant effects by several methods (Table 2). R. officinalis showed high antioxidant effects compared to
O. basilicum, as measured by all methods. Further, R. officinalis showed a comparable antioxidant effect to
rosmarinic acid. The highest antioxidant values (lowest IC50) were found in 3,4-Dihydroxyphenylacetic
acid and rosmarinic acid. Rutoside showed relatively low antioxidant effects as compared to other
identified compounds.
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Table 2. 2,2-diphenyl-1-picrylhydrazyl (DPPH),β-Carotene bleaching and ferric reducing antioxidant power
(FRAP) measures of R. officinalis and O. basilicum leaf extracts, rosmarininic acid, 3,4-dihydroxyphenylacetic
acid, gentisic acid, and rutoside.
DPPH (IC50, µg mL−1)
β-Carotene-Bleaching
Assay (IC50, µg mL−1)
FRAP (IC50, mM
TEAC/g Extract)
R. officinalis 2.9 ± 0.1c 3.6 ± 0.1c 4.1 ± 0.2e
O. basilicum 4.7 ± 0.1cd 5.1 ± 0.3d 5.5 ± 0.1e
Rosmarinic acid 2.6 ± 0.1d 3.0 ± 0.1d 3.3 ± 0.9f
3,4-Dihydroxyphenylacetic acid 2.1 ± 0.1d 2.7 ± 0.1d 3.2 ± 0.1d
Gentisic acid 5.8 ± 0.1d 7.3 ± 0.2d 9.5 ± 1.0f
Rutoside 14.3 ± 1.1d 16.5 ± 0.7d 18.6 ± 0.9d
BHT 2.6 ± 0.2e 3.1 ± 0.1e -
Trolox - - 3.1 ± 0.1g
Different letters within a column indicates significant differences (p ≤ 0.05). TEAC: Trolox equivalents antioxidant.
3.3. Antiproliferative and Cytotoxic Effects
The MTT assay of methanolic leaf extracts and identified phenols revealed obvious antiproliferative
effects against T-cell lymphoblast like (Jurkat), breast adenocarcinoma cultures (MCF-7), colon
adenocarcinoma (HT-29), cervical adenocarcinoma (HeLa), and HEK-293 (normal human cells),
as shown in Table 3. The 3,4-Dihydroxyphenylacetic acid and rutoside had the lowest IC50 values
compared to other compounds as well as leaf extracts.
The flow cytometry assay (Figure 2) showed the apoptotic cell accumulation the upper and lower
right quadrant, following 48 h of exposure.
Table 3. Antiproliferative activity (IC50 (µg mL−1)) of R. officinalis and O. basilicum leaf extracts,
rosmarinic acid, 3,4-dihydroxyphenylacetic acid, gentisic acid, and rutoside on cancer cells.
HeLa HT-29 MCF-7 Jurkat HEK-293
R. officinalis 39.52 ± 2.3 36.59 ± 2.7 38.29 ± 1.7 64.39 ± 3.1 >400
O. basilicum 45.26 ± 3.2 48.31 ± 2.9 47.23 ± 3.1 75.13 ± 3.6 >400
Rosmarinic acid 36.30 ± 1.3 24.27 ± 2.1 25.61 ± 2.5 47.43 ± 3.1 >400
3,4-Dihydroxyphenylacetic acid 3.11 ± 0.1f 20.41 ± 0.7 7.12 ± 0.9 5.63 ± 1.1 >400
Gentisic acid 5.7 ± 0.5 24.26 ± 0.9 10.13 ± 0.7 7.4 ± 0.6 >400
Rutoside 3.9 ± 01 17.5 ± 0.8f 5.0 ± 0.3f 4.0 ± 0.5 >400
Vinblastine sulfate 2.1 ± 0.04 16.3 ± 0.7 - 0.11 ± 0.01 42.7 ± 1.3
Taxol - - 0.07 ± 0.004 - -
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Figure 2. Cytot of R. officinalis and O. basilicum leaf extracts, and rosmarinic acid,
3,4-dihydroxyphenylaceti P C), and rutoside, as estimated with flow cytometry. There was an
accumulation of apoptotic cells in the early (lower right quadrant) and late apoptotic (upper right quadrant).
3.4. Antibacterial Effects
R. officinalis and O. basilicum methanolic leaf extracts had strong antibacterial effects against screened
bacteria (Table 4). Staphylococcus aureus, Pseudomonas aeruginosa, and Micrococcus flavus were the most
sensitive to leaf extracts. 3,4-dihydroxyphenylacetic acid, rutoside and caffeic acid were the most active
isolated compounds against most bacteria. Gentisic acid was not active against all bacterial except
Escherichia coli. Rosmarinic acid was weak against most bacteria and showed MBC > 500 mg mL−1.
Table 4. R. officinalis and O. basilicum leaf extracts, rosmarinic acid, 3,4-dihydroxyphenylacetic
acid, gentisic acid, and rutoside antibacterial activities by means of minimum inhibitory (MIC) and
bactericidal concentration (MBC) in (mg mL−1).
B. cereus P. aeruginosa L. monocytogenes E. coli M. flavus S. aureus
MIC MIC MIC MIC MIC MIC
MBC MBC MBC MBC MBC MBC
R. officinalis 0.56 ± 0.03 0.43 ± 0.03 0.54 ± 0.03 0.46 ± 0.02 0.36 ± 0.03 0.29 ± 0.03
0.97 ± 0.05 0.85 ± 0.03 0.96 ± 0.05 0.91 ± 0.03 0.82 ± 0.03 0.79 ± 0.02
O. basilicum
0.43 ± 0.03 0.32 ± 0.02 0.41 ± 0.01 0.35 ± 0.01 0.27 ± 0.02 0.23 ± 0.01
0.85 ± 0.05 0.75 ± 0.03 0.89 ± 0.03 0.68 ± 0.03 0.59 ± 0.03 0.56 ± 0.03
Rosmarinic acid
39.31 ± 1.13 37.2 ± 1.64 46.21 ± 3.12 42.1 ± 3.42 31.11 ± 1.53 23.31 ± 0.96
>500 >500 >500 >500 >500 >500
Gentisic acid
N.D. N.D. N.D. 23.00 ± 0.02 N.D. N.D.
N.D. N.D. N.D. >100 N.D. N.D.
3,4-Dihydroxyphenylacetic
acid
0.07 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.14 ± 0.02 0.13 ± 0.01
0.15 ± 0.01 0.13 ± 0.01 0.17 ± 0.01 0.19 ± 0.02 0.30 ± 0.02 0.27 ± 0.02
Rutoside
0.10 ± 0.01 0.06 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.13 ± 0.01 0.12 ± 0.01
0.20 ± 0.01 0.11 ± 0.01 0.20 ± 0.02 0.24 ± 0.01 0.24 ± 0.02 0.24 ± 0.02
Caffeic acid
0.12 ± 0.01 0.06 ± 0.01 0.25 ± 0.01 0.10 ± 0.01 0.12 ± 0.01 0.21 ± 0.01
0.29 ± 0.03 0.12 ± 0.01 0.55 ± 0.03 0.23 ± 0.02 0.29 ± 0.02 0.43 ± 0.03
Streptomycin 0.07 ± 0.01 0.09 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.15 ± 0.01
0.16 ± 0.01 0.19 ± 0.01 0.23 ± 0.01 0.21 ± 0.01 0.21 ± 0.01 0.31 ± 0.01
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3.5. Antifungal Activities
R. officinalis and O. basilicum methanolic leaf extracts showed antifungal activities against all fungi
screened (Table 5). R. officinalis showed lower IC50 values than O. basilicum. 3,4-Dihydroxyphenylacetic
acid, gentisic acid, rutoside, and caffeic acid showed strong antifungal activities against
examined bacteria. Rosmarinic acid showed the weakest antifungal effects compared to other
identified polyphenols.
Table 5. Minimum inhibitory (MIC) and fungicidal concentration (MFC) of R. officinalis and O. basilicum
leaf extracts, rosmarinic acid, 3,4-dihydroxyphenylacetic acid, gentisic acid and rutoside. Values are
means of 3 replicates in (mg mL−1).
Aspergillus
flavus
Aspergillus
ochraceus Aspergillus niger
Candida
albicans
Penicillium
funiculosum
Penicillium
ochrochloron
MIC MIC MIC MIC MIC MIC
MFC MFC MFC MFC MFC MFC
R. officinalis 0.49 ± 0.05 0.56 ± 0.03 0.69 ± 0.03 0.86 ± 0.03 0.42 ± 0.03 0.49 ± 0.05
0.96 ± 0.05 1.18 ± 0.13 1.23 ± 0.07 1.59 ± 0.15 0.87 ± 0.05 0.93 ± 0.05
O. basilicum
0.31 ± 0.02 0.38 ± 0.05 0.54 ± 0.05 0.63 ± 0.09 0.35 ± 0.03 0.38 ± 0.01
0.74 ± 0.03 0.89 ± 0.03 1.01 ± 0.09 1.16 ± 0.08 0.76 ± 0.05 0.89 ± 0.03
Rosmarinic acid
181.92 ± 8.47 222.32 ± 9.18 231.65 ± 8.69 385.7 ± 15.76 218.86 ±11.78 349.9 ± 11.45
>1000 >1000 >1000 >1000 >1000 >1000
Gentisic acid
0.20 ± 0.03 0.15 ± 0.01 0.24 ± 0.03 0.29 ± 0.03 0.23 ± 0.01 0.18 ± 0.02
0.53 ± 0.05 0.49 ± 0.03 0.58 ± 0.04 0.65 ± 0.05 0.52 ± 0.03 0.43 ± 0.04
3,4-Dihydroxyphenylacetic
acid
0.19 ± 0.01 0.21 ± 0.02 0.25 ± 0.02 0.28 ± 0.03 0.27 ± 0.03 0.21 ± 0.01
0.41 ± 0.03 0.45 ± 0.03 0.51 ± 0.04 0.63 ± 0.05 0.63 ± 0.04 0.45 ± 0.05
Rutoside
0.20 ± 0.02 0.19 ± 0.01 0.29 ± 0.03 0.24 ± 0.03 0.31 ± 0.02 0.21 ± 0.03
0.45 ± 0.03 0.56 ± 0.03 0.64 ± 0.05 0.53 ± 0.03 0.73 ± 0.04 0.47 ± 0.05
Caffeic acid
0.21± 0.02 0.23 ± 0.01 0.20 ± 0.02 0.31 ± 0.01 0.26 ± 0.01 0.20 ± 0.01
0.43 ± 0.03 0.46 ± 0.03 0.40 ± 0.03 0.63 ± 0.03 0.61 ± 0.04 0.42 ± 0.03
KTZ (Ketoconazolum)
0.22 ± 0.02 0.20 ± 0.01 0.10± 0.01 0.22 ± 0.01 2.00 ± 0.11 0.22 ± 0.01
0.45 ± 0.03 0.41 ± 0.03 0.21 ± 0.02 0.43 ± 0.03 3.54 ± 0.10 0.44 ± 0.03
4. Discussion
The rosmarinic acid in R. officinalis leaf extracts has been reported by several authors. However,
the qualitative estimations are limited. Borrás-Linare et al. [43] studied 20 rosemary plants (harvested
from different geographical zones of Serbia) by HPLC–ESI-QTOF-MS (high performance liquid
chromatography coupled to electrospray quadrupole-time of flight mass spectrometry) method.
The amount of rosmarinic acid varied from 50 to 2500 mg/100 g DW, depending on the place of harvest.
Interestingly, the amount of rosmarinic acid quantified in their study was 1.6 times lower than that
found in the North Saudi Arabia natural population origin samples in the current study. The rosmarinic
acid was the unique phenolic acid confirmed by Kontogianni et al. [44] in the extracts of R. officinalis
leaf commercial samples (Greece) using liquid chromatography/diode array detection/electrospray
ion trap tandem mass spectrometry (LC/DAD/ESI-MS) method. The amount of rosmarinic acid from
Greece [44] was equal to 1160 mg/100 g DW, which is 3.5 times lower than in the R. officinalis plants of
Saudi origin of this study. The rosmarinic and caffeic acids in the R. officinalis leaf extracts samples
obtained from United Kingdom ranged from 1000.0 to 1100.0 and from 10.0 to 20.0 mg/100 g DW,
respectively [45]. These amounts were respectively c.a. 3.8 and 1.8 times lower than in the Saudi
extracts of the present study. The vanillic acid was quantified (4 mg/100 g DW) by Luis et al. [46] in
the leaf extracts of R. officinalis from United Kingdom. That amount was 9 times lower than in the
samples of our collection. In addition, the same researchers detected rosmarinic acid (2150 mg/100 g
DW) and caffeic acid (12 mg/100 g DW) in amounts respectively 1.9 and 2.3 times lower than the North
Saudi Arabia natural population origin samples. Zgórka and Głowniak studied the compositions some
phenolic acids in R. officinalis leaf extracts of Polish origin [47]. They detected relatively low amount of
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rosmarinic acid—c.a. 700 mg/100 g DW (5.8 times lower than in Saudi origin samples), caffeic acid—c.a.
25 mg/100 g DW (similar to Saudi origin samples) and vanillic acid—c.a. 15 mg/100 g DW (1.8 times
lower Saudi origin samples). They also confirmed the gentisic acid in the extracts in amount 2 times
lower than the current study samples (c.a. 50 mg/100 g DW).
In O. basilicum leaf extracts, the HPLC-DAD analyses revealed high amount of rosmarinic acid
(1128.5 mg/100 g DW). This compound is generally recognized as typical for the Lamiaceae family
species. For example, there are many studies describing the endogenous synthesis of high amounts
of this compound of in vitro cultured biomass of O. basilicum of a different origin [48]. The phenolic
composition of O. basilicum leaf extracts has not been studied deeply. One study investigated 16 different
O. basilicum cultivars from North America [49]. There were considerable differences between tested
cultivars and the main compound was rosmarinic acid (varied from 6 to 609 mg/100 g DW), followed
by caftaric acid (from 9 to 49 mg/100 g DW) and caffeic acid (from 4 to 77 mg/100 g DW). These North
American plants compositions of rosmarinic acid and caftaric acid were respectively 1.8 and 1.2 times
lower than in the samples of Saudi origin, also the caffeic acid was 4.4 times higher. In O. basilicum
plants from Iraq, the rosmarinic acid composition was equal to 306 mg/100 g DW, which is several
times lower than Saudi one [50]. Zgórka and Głowniak [47] studied leaf extracts of Polish O. basilicum
and they detected rosmarinic acid—c.a. 1100 mg/100 g DW, which is comparable to Saudi origin
samples. Moreover, they confirmed also: caffeic acid—c.a. 270 mg/100 g DW (15 times more
than in Ssaudi origin samples) and vanillic acid—c.a. 8 mg/100 g DW (7 times more than Saudi
origin samples). The rosmarinic acid is the ester of caffeic acid with 3,4-dihydroxyphenylacetic acid
(α-hydroxydihydrocaffeic acid). In the Saudi O. basilicum leaf extracts samples, we confirmed a
high amount of 3,4-dihydroxyphenylacetic acid (α-hydroxydihydrocaffeic acid) (312.3 mg/100 g DW)
and caffeic acid (17.6 mg/100 g DW). Vlase et al. studied the phenolic composition of O. basilicum
leaf extracts of Romanian origin [51], and the major compound was rutoside (42.57 mg/100 g DW).
The amount of rutoside was 3 times higher in the Saudi Samples than those of Romanian origin. In the
Romanian samples, they also confirmed the availability of ferulic acid (0.7 mg/100 g DW), p-coumaric
acid (2.1 mg/100 g DW), and trace amounts (below 0.02 mg/1000 g DW) of caffeic acid, caftaric acid,
chlorogenic acid and rosmarinic acid. In the Saudi plants, we detected considerably high amounts
of these compounds, especially for chlorogenic acid derivatives—caftaric acid (60.3 mg/100 g DW),
neochlorogenic acid (38.6 mg/100 g DW)—as well as isochlorogenic acid (30.0 mg/100 g DW).
Leaf extracts of R. officinalis and O. basilicum showed antioxidant effects, as revealed by several
methods. The antioxidant activity of Northern Riyadh R. officinalis leaf extracts is mainly attributed
to major identified polyphenols including rosmarinic acid. The rosmarinic acid showed comparable
antioxidant activities to R. officinalis leaf extracts. Previous investigation on R. officinalis from Morocco
revealed antioxidant activities of ethanolic leaf extracts, and this was attributed to the major identified
polyphenols, including carnosol and carnosic acid [52]. Other reports indicated that the major leaf
extract polyphenols responsible for antioxidant activities might be rosmarinic acid, hesperidin, and
rosmanol as well [53]. The rosmarinic acid itself has strong antioxidant activities, as found in this
study, as well as in previous investigations [54]. Other compounds that were also present in the
extracts of rosemary in this study, including gentisic acid, showed antioxidant activities and have
been associated with antioxidant activities against gamma irradiation [25] and as an antioxidant agent
food industries [32]. In O. basilicum, there were also antioxidant activities in leaf extracts, and this
might be attributed to major identified polyphenols including rosmarinic acid, DOPAC and rutoside.
DOPAC, has known antioxidant activities as revealed in previous studies [55]. Rutoside (rutin) is
known also as potent antioxidant [56]. Previous studied revealed antioxidant activities of leaf extracts
of O. basilicum [24,25,57].
Antiproliferative and cytotoxic activities against Jurkat, MCF-7, HT-29, and HeLa were found
in the methanolic leaf extracts of R. officinalis in the current study. It was attributed to DOPAC and
rosmarinic acid, as found in the MTT assay and flowcytometry. A previous report found that rosemary
leaf extracts (from Germany) may have antiproliferative activities against human ovarian cancer A2780,
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and this activity might be attributed to main detected polyphenols such as carnosol, carnosic acid, and
rosmarinic acid [58]. They described the perturbation of cell cycle progression in different phases of the
cell cycle in response to leaf extract treatment. In the current study, there was an accumulation of necrotic
and apoptotic cells in treated samples with the Saudi rosemary leaf extracts. The effects of rosmarinic
acid and DOPAC on cancer cells had been described before. A previous investigation showed that
rosemary leaf extracts had antiproliferative activities against HT-29 cancer cells by inhibiting cell
proliferation, increasing cell cycle arrest, and increasing apoptosis [59]. The major composition of
this extract was the rosmarinic acid [60]. The rosmarinic acid has strong anticancer activities against
MCF-7 [61] and HT-29 [62]. The DOPAC has antiproliferative activities against few cancer cells, such as
CHO-K1 [63]. In the current study, O. basilicum leaf extracts showed noticeable antiproliferative and
cytotoxic activities against cancer cells, and this could be attributed to the polyphenolic composition,
including rosmarinic acid, DOPAC, rutoside, ferulic acid, caffeic acid. Egyptian O. basilicum showed
leaf methanolic extracts showed cytotoxic activities against HCT116 and HEBG2 cancer cells, and this
was attributed to the phenolic composition, including caffeic acid, ferulic acid, catechin, quercetin,
and others [64]. These polyphenols had known antiproliferative and cytotoxic activities, for example
the rutoside obtained from Ferocactus species showed strong antiproliferative and cytotoxic activities
against cancer cells [39].
The leaf extracts obtained from Saudi R. officinalis and O. basilicum had strong antibacterial and
antifungal effects against screened bacteria and fungi. S. aureus, P. aeruginosa, and M. flavus were the
most sensitive to leaf extracts. The antibacterial activity of leaf extracts is associated with some major
polyphenols including DOPAC and rutoside. However, other polyphenols, including gentisic acid and
rosmarinic acid were not relatively active. The antibacterial activity of DOPAC had been reported before
against several bacteria [39]. Rutoside also has antibacterial activities against B. cereus and Salmonella
enteritidis [65], S. aureus [66], and other bacteria [39]. R. officinalis and O. basilicum (from different
regions) leaf extracts showed antibacterial activities in previous investigations [67]. Caffeic acid showed
strong antibacterial activities, which is in agreement with previous studied confirming the antibacterial
activities against different bacteria [5].
The antifungal activities of R. officinalis and O. basilicum methanolic leaf extracts had been reported
before against several fungi [68]. However, this is the first report on the antifungal activities of R.
officinalis from Northern Saudi Arabia. These antifungal activities are strongly associated with identified
polyphenols, including 3,4-dihydroxyphenylacetic acid, gentisic acid, and rutoside. Gentisic acid is a
dihydroxybenzoic acid that have known antifungal activities [69]. Similarly, DOPAC, rutoside, and
caffeic acid had strong antifungal activities [5,39].
5. Conclusions
This is a novel report exploring the polyphenolic profile of natural populations of
R. officinalis and O. basilicum in Northern Riyadh in Saudi Arabia. The HPLC-DAD analyses
confirmed several polyphenols, including rosmarinic acid, gentisic acid, 3,4-dihydroxyphenylacetic
acid (α-hydroxydihydrocaffeic acid), rutoside, and others out of 38 screened polyphenolic
compounds. Rosmarinic acid was the major polyphenol in both studied species. R. officinalis methanolic
leaf extracts contained rosmarinic acid and gentisic acid as major polyphenols, while O. basilicum
contained rosmarinic acid, 3,4-dihydroxyphenylacetic acid, and rutoside, as well as others. R. officinalis
showed higher antioxidant activities than O. basilicum using DPPH, FRAP, and β-carotene bleaching
assay. These higher activities are associated with a higher composition of rosmarinic acid in leaf
extracts. The antioxidant activities of O. basilicum were attributed to identified phenols of rosmarinic
acid, 3,4-dihydroxyphenylacetic acid, and rutoside. There were antiproliferative and cytotoxic activities
of leaf extracts, as well as identified polyphenols against several cancer cells. These activities were
attributed to the accumulation of necrotic and apoptotic cells in treated cancer cells, with leaf extracts as
well as identified polyphenols. The antibacterial and antifungal activities of leaf extracts were mainly
attributed to 3,4-dihydroxyphenylacetic acid and rutoside in O. basilicum and rosmarinic acid and
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caffeic acid in R. officinalis. This study proved that R. officinalis and O. basilicum natural populations
might be considered as promising sources of natural polyphenols with biological activities.
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